Adient (NYSE:ADNT - Get Free Report) had its price objective lifted by UBS Group from $25.00 to $26.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a "neutral" rating on the stock. UBS Group's price target points to a potential upside of 13.86% from the stock's current price.
Several other equities analysts have also issued reports on ADNT. Morgan Stanley reduced their price target on Adient from $17.00 to $16.00 and set an "underweight" rating on the stock in a research report on Monday, May 19th. Citigroup began coverage on Adient in a report on Wednesday, April 23rd. They set a "neutral" rating and a $14.00 price target for the company. Wall Street Zen upgraded Adient from a "hold" rating to a "buy" rating in a report on Friday, July 18th. Wells Fargo & Company raised their target price on Adient from $17.00 to $18.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 1st. Finally, Bank of America upped their price target on Adient from $15.00 to $17.50 and gave the company an "underperform" rating in a research report on Monday, June 16th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $20.94.
Check Out Our Latest Stock Report on Adient
Adient Trading Down 0.2%
Shares of ADNT stock traded down $0.05 on Thursday, reaching $22.84. The company had a trading volume of 336,717 shares, compared to its average volume of 1,454,315. The stock has a market cap of $1.92 billion, a PE ratio of -7.14, a PEG ratio of 0.79 and a beta of 1.72. Adient has a 12 month low of $10.04 and a 12 month high of $24.25. The company has a 50-day moving average of $20.24 and a 200-day moving average of $16.51. The company has a current ratio of 1.11, a quick ratio of 0.90 and a debt-to-equity ratio of 1.22.
Adient (NYSE:ADNT - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Adient had a negative net margin of 1.86% and a positive return on equity of 7.70%. The business had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.56 billion. During the same quarter in the prior year, the firm earned $0.32 EPS. The business's revenue was up .7% on a year-over-year basis. On average, equities analysts forecast that Adient will post 1.76 earnings per share for the current year.
Hedge Funds Weigh In On Adient
A number of hedge funds have recently bought and sold shares of ADNT. Fox Run Management L.L.C. bought a new stake in Adient in the 2nd quarter worth about $578,000. Savant Capital LLC purchased a new stake in shares of Adient during the 2nd quarter worth $243,000. Corton Capital Inc. acquired a new position in Adient during the 2nd quarter valued at about $315,000. Bank of Montreal Can increased its position in Adient by 16.0% during the 2nd quarter. Bank of Montreal Can now owns 16,208 shares of the company's stock valued at $315,000 after buying an additional 2,238 shares in the last quarter. Finally, Aequim Alternative Investments LP acquired a new position in shares of Adient in the second quarter valued at about $1,362,000. 92.44% of the stock is owned by hedge funds and other institutional investors.
Adient Company Profile
(
Get Free Report)
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Adient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.
While Adient currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.